Rockbridge Investment Management, Lcc Novartis Ag Transaction History

Rockbridge Investment Management, Lcc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $85,811 - $94,432	930 Added 395.74%	1,165 $118 Million
Q3 2022 May 28, 2024	SELL	$74.61 - $87.26 $17,533 - $20,506	-235 Closed	0 $0
Q1 2022 May 28, 2024	BUY	$80.11 - $90.62 $18,825 - $21,295	235 New	235 $20,000
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $10,713 - $12,463	-131 Reduced 35.79%	235 $19,000
Q1 2021 May 20, 2021	BUY	$83.5 - $98.47 $6,680 - $7,877	80 Added 27.97%	366 $31,000
Q2 2020 Aug 20, 2020	BUY	$80.93 - $91.1 $23,145 - $26,054	286 New	286 $25,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.